Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657382 · ClinicalTrials.gov registry record · NA
Mental Stress Ischemia: Biofeedback Study
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02657382: Completed NA study, sponsored by Emory University.
NCT02657382 is a NA study that has completed, run by Emory University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657382, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the blood flow to the heart during stress and assess changes in blood flow after psychological treatment in participants with coronary artery disease. The aims of the study are to assess the effects of heart rate variability (HRV) biofeedback (versus usual care) on global and regional myocardial blood flow (MBF), peripheral vascular function, and autonomic changes during mental stress.
Primary Outcome
Global myocardial perfusion during mental stress will be tested via positron emission topography (PET) scan while completing the mental stress protocol.
Interventions
- BEHAVIORAL Heart Rate Variability (HRV) Biofeedback (BF)
- OTHER Mental Stress Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-06-24 |
| Phase | NA |
What the finished NCT02657382 record still lists
NCT02657382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Heart Rate Variability (HRV) Biofeedback (BF) is the first listed.
NCT02657382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02657382 about?
NCT02657382 is a clinical study titled "Mental Stress Ischemia: Biofeedback Study". The purpose of this study is to evaluate the blood flow to the heart during stress and assess changes in blood flow after psychological treatment in participants with coronary artery disease. The aims of the study are to assess the effects of heart rate variability (HRV) biofeedback (versus usual ca...
What is the current status of trial NCT02657382?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-09. Estimated completion is 2020-06-24.
What interventions are being tested in trial NCT02657382?
The interventions under investigation include: Heart Rate Variability (HRV) Biofeedback (BF) (BEHAVIORAL), Mental Stress Protocol (OTHER).
Who is sponsoring clinical trial NCT02657382?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02657382's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia